drugset
drugset / Trial / NCT05793632

Quetiapine in Prevention of Delirium

NCT05793632 ↗

Phase 2 Completed 90 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim is to study the effectiveness of Quetiapine in preventing delirium in the elderly patients with multiple risks for delirium.

Timeline

Start
2023-03-01
Primary completion
2023-04-01
Completion
2023-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 25 mg Oral

Indications

delirium